Source: Annual Congress 2012 - Occupational asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Munoz, I. Martínez-González, J.M. Aran, O. Roca, F. Morell, M.J. Cruz (Barcelona, Spain). Therapeutic potential of mesenchymal stem cells modified to secrete anti-inflammatory protein sST2 in a model of occupational asthma. Eur Respir J 2012; 40: Suppl. 56, 1019

Member's Comments

Burge Sherwood - 01.09.2012 12:18
If I am chairing this discusssion I will need help with sST2 and its significance

Related content which might interest you: Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Therapeutic effects of human perivascular stem cells in an emphysema mouse model Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Therapeutic potential of mesenchymal stem cells to attenuate immune cell tolerance in a late stage model of sepsis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Effects of hypercapnic acidosis on the primary cells relevant to ARDS pathophysiology and the therapeutic potential of mesenchymal stem cells Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Mast cells in asthma: biomarker and therapeutic target Source: Eur Respir J 2016; 47: 1040-1042 Year: 2016 The antiinflammatory effect of statins on human bronchial epithelial cells Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 The antiinflammatory effect of statins on human bronchial epithelial cells Source: Annual Congress 2008 - Airway cell biology Year: 2008 Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015